Literature DB >> 17273158

Age- and gender-dependent association of the -344C/T polymorphism of CYP11B2 with blood pressure in European populations.

P Russo, M Loguercio, F Lauria, G Barba, J Arnout, F P Cappuccio, L Iacoviello, A Siani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273158     DOI: 10.1038/sj.jhh.1002136

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  5 in total

1.  Distribution and phenotypic expression of mineralocorticoid receptor and CYP11B2 T-344C polymorphisms in a Taiwanese hypertensive population.

Authors:  Sung-Kien Sia; Hui-Ling Chiou; Shiuan-Chih Chen; Chin-Feng Tsai; Shun-Fa Yang; Kwo-Chang Ueng
Journal:  Mol Biol Rep       Date:  2012-12-29       Impact factor: 2.316

2.  Glutathione S-transferase variants as risk factor for essential hypertension in Italian patients.

Authors:  Renato Polimanti; Sara Piacentini; Natalia Lazzarin; Maria Antonietta Re; Dario Manfellotto; Maria Fuciarelli
Journal:  Mol Cell Biochem       Date:  2011-06-09       Impact factor: 3.396

3.  E-selectin gene polymorphisms are associated with essential hypertension: a case-control pilot study in a Chinese population.

Authors:  Zuoguang Wang; Ya Liu; Jieling Liu; Kuo Liu; Yuqin Lou; Jie Wen; Qiuli Niu; Shaojun Wen; Zhaosu Wu
Journal:  BMC Med Genet       Date:  2010-08-27       Impact factor: 2.103

4.  Biomarkers of antioxidant status and lipid peroxidation in elderly patients with hypertension.

Authors:  Hanna Pawluk; Robert Pawluk; Joanna Robaczewska; Kornelia Kędziora-Kornatowska; Józef Kędziora
Journal:  Redox Rep       Date:  2017-09-05       Impact factor: 4.412

5.  Genetic variation of NEDD4L is associated with essential hypertension in female Kazakh general population: a case-control study.

Authors:  Nanfang Li; Hongmei Wang; Jin Yang; Ling Zhou; Jing Hong; Yanying Guo; Wenli Luo; Jianhang Chang
Journal:  BMC Med Genet       Date:  2009-12-09       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.